Pamlab, Inc. clinical trials

Acquired by Alfasigma S.p.A.

The registry lists 13 studies whose lead sponsor is Pamlab, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 3, 2016.

Studies

Recruiting first, then most recently updated. Showing 13 of 13. All Alfasigma S.p.A. studies →

• A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia PatientsCompletedNCT01091506Not applicable

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)Status unknownNCT01990092Not applicable

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• Effect of Cerefolin®/CerefolinNAC® on Biomarker MeasurementsCompletedNCT01745198

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)CompletedNCT01369030

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired PatientsStatus unknownNCT01594541

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective AnalysisCompletedNCT01001559

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)CompletedNCT00726713Phase 4

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)CompletedNCT01370954

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)TerminatedNCT01358552

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During PregnancyCompletedNCT01062958

  Sponsor listed in the registry: Pamlab, Inc. · Pamlab, Inc. — acquired company within the Alfasigma S.p.A. group

• Administrative Claims Analysis of Metanx® in Diabetic Peripheral NeuropathyCompletedNCT01247558

  Sponsor listed in the registry: Pamlab, L.L.C. · Pamlab, L.L.C. — acquired company within the Alfasigma S.p.A. group

• Metanx® P.L.U.S. Program (Progress Through Learning, Understanding & Support)Status unknownNCT01368549

  Sponsor listed in the registry: Pamlab, L.L.C. · Pamlab, L.L.C. — acquired company within the Alfasigma S.p.A. group

• A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During PregnancyTerminatedNCT01193192

  Sponsor listed in the registry: Pamlab, L.L.C. · Pamlab, L.L.C. — acquired company within the Alfasigma S.p.A. group